Wednesday, February 19, 2025



Home Industry Healthcare Russia to Launch Personalized ...

Russia to Launch Personalized mRNA Cancer Vaccine in 2025


Healthcare

Russia, Cancer, Vaccine, Andrey Kaprin

Russia is set to launch a revolutionary mRNA-based cancer vaccine in 2025, offering personalized treatment for patients.

Russia will soon unveil a revolutionary mRNA-based vaccine in early 2025 to treat cancer patients. This personalized vaccine, which takes genetic material from a patient's tumor, will be made available to Russian citizens without cost, according to reports from state-run media. It costs the state around 300,000 rubles (USD 2,869) per dose. The vaccine is intended to treat already existing cancer, rather than prevent the formation of tumors.

The news was announced by the head of the Radiology Medical Research Centre at the Ministry of Health, Andrey Kaprin. According to him, it is based on a method by which the immune system learns to recognize and then attack cancer cells. "This vaccine is designed for cancer treatment rather than the prevention of tumor formation," he said.

Alexander Gintsburg, the head of the Gamaleya National Research Centre for Epidemiology and Microbiology, shed light on the complexity of vaccine production. He said the personalized vaccine is produced thanks to the work of AI and neural networks. The Ivannikov Institute is reportedly participating in the process of elaboration using the advanced mathematical models according to each patient's tumor, and this will take 30 minutes to one hour to prepare.

The vaccine works based on the principle of recognizing antigens specific to cancerous cells. Once it has entered the body, these antigens trigger the immune system to produce antibodies that fight against and kill cancerous cells. According to recent statistics, there has been an increase in cancer rates in Russia. As many as 635,000 new cases were reported in 2022. The three common types of cancer reported are colon, breast, and lung cancers.

This innovation follows similar efforts in Western countries. In the U.S., researchers at the University of Florida have tested an individualized vaccine for glioblastoma, an aggressive brain cancer. Early trials in the UK for melanoma have also shown promising results, with improved survival rates.


Business News


Recommended News

×

Subscribe To Our Newsletter

please enter valid email

×